HIV to HIV Transplantation: Hope in Action

Christine M. Durand, MD
Assistant Professor of Medicine, Division of Infectious Diseases
Transplant Oncology Group
Johns Hopkins School of Medicine, Baltimore, MD



CME VIDEOTop of page

About the Presenter: Top of page

Christine Durand holds a unique position within the Division of Infectious Diseases at Johns Hopkins—she is the only faculty member with a dual appointment in both the HIV group and Transplant Oncology ID group. She leads the evaluation and management of all HIV-infected and HCV-infected solid organ and bone marrow transplant candidates, and her current research includes epidemiologic, translational and clinical studies focused on this patient population. Dr Durand also has experience working with national cooperative groups in the areas of HIV, HCV, cancer and transplant. She is PI for follow-up studies to the NIH-funded Multisite HIV+ organ transplant study, and currently leads translational studies measuring HIV reservoirs in 4 ongoing trials led by the AIDS Malignancy Consortium and Blood and Marrow Transplant Clinical Trials Network. Additionally, Dr Durand is also the Johns Hopkins site PI for several ongoing clinical trials of HIV and HCV treatment, and holds a leadership position in the translational science working groups of both the AMC and the AIDS Clinical Trials Group. Dr Durand is the PI of the first pilot study of HIV-to-HIV kidney and liver transplant at Johns Hopkins, and is currently leading a national consortium of more than 30 transplant centers that are organizing efforts to study HIV-to-HIV transplant at sites across the country.

Learning Objectives: Top of page

At the completion of this educational session, learners will:
  • Know the guidelines to select appropriate HIV-positive candidates for organ transplantation.
  • Understand the management challenges for HIV-positive transplant recipients.
  • Be aware of the recent changes in federal law allowing for the use of HIV-positive donors.
  • Appreciate the knowledge gaps and risks of using HIV-positive donors.

CME Information: Top of page


This CME activity was approved for AMA PRA Category 1 Credit™ on June 14, 2016 and will terminate June, 13, 2019.

The target audience is all physicians, NPs and PAs involved or interested in HIV education.

This online video and post-activity evaluation are one hour in length.
  • After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
  • You must achieve at least 70% correct to receive your CME certificate.
  • If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
  • Accreditation Statement: Top of page


    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.

    The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with extent of their participation in the activity.

    Disclosure Statement: Top of page


    Policies and standards of MSSNY require that speakers and planners for CME activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity.
  • Dr. James Braun (Planner/Course Director) had no relevant financial relationships to disclose.
  • Dr. Christine Durand (Presenter) had the following personal financial relationships in the prior 12 months with manufacturers of the products or services that may be presented in this CME activity: Advisory boards of Gilead, BMS, and Merck; research grants from Gilead, and BMS; review panel member with Gilead. Dr. Durand submitted her slides in advance for adequate peer review, and will support her presentation and clinical recommendations with the best available evidence from the medical literature.
  • Financial Support: Top of page

    This PRN CME activity is funded in part by unrestricted educational grants from: Bristol-Myers Squibb, Gilead Sciences, Merck & Co, and ViiV Healthcare.

    How to Obtain CME Credit: Top of page

    To obtain CME credit for this PRN program, please visit the PRN Video Channel at the Clinical Education Initiative (CEI) web site. PRN and the Medical Society of the State of New York (MSSNY) jointly sponsor PRN enduring materials for CME, and provide them at no cost to the AIDS Institute of the New York State Department of Health (NYSDOH) for broadcast through the CEI. We thank the NYSDOH for making our CME programs available to a wider audience, and hope you will also browse the many other educational opportunities offered by the CEI.

    You must be logged in to post a comment. Login | Register